Characteristics of the N=20 key informants
| Profession | Country | Gender | Provider | Expert* | Patient |
|---|---|---|---|---|---|
| Pharmacologist | Australia | Female | X | ||
| Professor medical psychology | Canada | Female | R | ||
| Professor general practice | Canada | Male | C+R | ||
| Professor epidemiology | Canada | Male | C+R | ||
| CPG developer | Germany | Female | C | ||
| General practitioner | Netherlands | Male | R | ||
| Professor general practice | Netherlands | Female | X | R | |
| Occupational physician | Netherlands | Female | C+P | X | |
| Professor surgery | Netherlands | Male | X | R | |
| Professor psychiatry | Netherlands | Male | X | R | |
| Radiology technician | Netherlands | Female | X | ||
| Manager | New Zealand | Female | X | ||
| Professor internal medicine | Switzerland | Male | X | C | |
| Professor health services research | UK | Female | R | ||
| CPG developer | UK | Female | C | ||
| CPG developer | UK | Male | C | ||
| Professor internal medicine | USA | Male | X | C+R | |
| General internist | USA | Female | X | R+P | |
| CPG developer | USA | Female | C | ||
| Health policy specialist | USA | emale | P | X |
*C=CPG developer, R=researcher, P=policy maker.
CPG, clinical practice guideline.